T1	Condition 45 48	SCD
T2	Condition-Name 45 48	SCD
E1	Condition:T1 Name:T2
T3	Condition 52 55	MCI
T4	Condition-Name 52 55	MCI
E3	Condition:T3 Name:T4
T5	Condition 482 504	coronary heart disease
T6	Condition-Name 482 504	coronary heart disease
E5	Condition:T5 Name:T6 Stability:T77
T7	Condition 426 439	brain disease
T8	Condition-Name 426 439	brain disease
E7	Condition:T7 Name:T8
T9	Condition 508 521	heart failure
T10	Condition-Name 508 521	heart failure
E9	Condition:T9 Name:T10
T11	Condition 457 467	depression
T12	Condition-Name 457 467	depression
E11	Condition:T11 Name:T12 Severity:T76
T13	Condition 322 330	Dementia
T14	Condition-Name 322 330	Dementia
E13	Condition:T13 Name:T14
T15	Condition 383 391	dementia
T16	Condition-Name 383 391	dementia
E15	Condition:T15 Name:T16
T17	Procedure 701 714	chemo-therapy
T18	Procedure-Name 701 714	chemo-therapy
E17	Procedure:T17 Name:T18
T19	Procedure 687 696	radiation
T20	Procedure-Name 687 696	radiation
E19	Procedure:T19 Name:T20 Temporality:E48
T23	Eq-Operator 29 30	>
A1	Eq-Operator-Value T23 GT
T24	Eq-Operator 348 349	<
A2	Eq-Operator-Value T24 LT
T25	Eq-Operator 364 367	>/=
A3	Eq-Operator-Value T25 GTEQ
T26	Eq-Operator 807 808	<
A4	Eq-Operator-Value T26 LT
T27	Eq-Temporal-Unit 34 39	years
A5	Eq-Temporal-Unit-Value T27 year
T28	Eq-Temporal-Unit 267 273	months
A6	Eq-Temporal-Unit-Value T28 month
T29	Eq-Temporal-Unit 811 816	years
A7	Eq-Temporal-Unit-Value T29 year
T30	Eq-Temporal-Unit 925 931	months
A8	Eq-Temporal-Unit-Value T30 month
T32	Age 25 28	Age
E22	Age:T32 Eq-Comparison:E23
T33	Eq-Value 31 33	50
T35	Eq-Value 265 266	3
T36	Eq-Value 350 352	26
T37	Eq-Value 368 369	1
T38	Eq-Value 809 810	5
T39	Eq-Value 849 850	2
T41	Eq-Value 923 924	3
T42	Eq-Comparison 29 39	> 50 years
E23	Eq-Comparison:T42 Operator:T23 Temporal-Unit:T27 Value:T33
T43	Eq-Comparison 348 352	< 26
E24	Eq-Comparison:T43 Operator:T24 Value:T36
T44	Eq-Comparison 807 816	< 5 years
E25	Eq-Comparison:T44 Operator:T26 Temporal-Unit:T29 Value:T38
T31	Or 49 51	or
E2	Or:T31 Arg:E1 Arg2:E3
T45	Condition 76 93	neurodegeneration
E4	Condition:T45 Name:T46
T46	Condition-Name 76 93	neurodegeneration
T47	Negation 61 63	No
E6	Negation:T47 Negates:E4
T21	Observation 100 111	CSF phospho
E8	Observation:T21 Name:T22 Eq-Comparison:E12
T22	Observation-Name 100 111	CSF phospho
A9	Observation-Type-Value T22 lab
T48	Observation 116 132	total tau-levels
E10	Observation:T48 Name:T49 Eq-Comparison:E12
T49	Observation-Name 116 132	total tau-levels
A10	Observation-Type-Value T49 lab
T50	Eq-Comparison 133 146	below cut-off
E12	Eq-Comparison:T50 Operator:T51 Unit:T52
T51	Eq-Operator 133 138	below
A11	Eq-Operator-Value T51 LT
T52	Eq-Unit 139 146	cut-off
A12	Eq-Unit-Value T52 ref-range-low
T53	Or 112 115	and
E14	Or:T53 Arg:E8 Arg2:E10
R1	Example-Of Arg1:E8 Arg2:E4	
T54	Language 153 165	Scandinavian
T34	Study 223 228	study
E16	Study:T34 
T55	Other 219 222	DDI
E18	Other:T55 Is-Other:E16
T56	Eq-Comparison 195 201	2-year
E20	Eq-Comparison:T56 Temporal-Unit:T58 Value:T57
T57	Eq-Value 195 196	2
T58	Eq-Temporal-Unit 197 201	year
A13	Eq-Temporal-Unit-Value T58 year
T59	Encounter 202 211	follow-up
E21	Encounter:T59 Duration:E20
T60	Temporal-Connection 212 214	in
E26	Temporal-Connection:T60 Arg:E21 Arg2:E16
A14	Temporal-Connection-Type-Value E26 during
T61	Drug 241 251	medication
E27	Drug:T61 Stability:T62 Temporality:E28
T62	Stability 234 240	Stable
A15	Stability-Value T62 stable
T63	Eq-Comparison 256 273	at least 3 months
E28	Eq-Comparison:T63 Operator:T64 Temporal-Unit:T28 Value:T35
T64	Eq-Operator 256 264	at least
A16	Eq-Operator-Value T64 GTEQ
T65	Temporal-Connection 274 279	prior
E29	Temporal-Connection:T65 Arg:E28 Arg2:E30
A17	Temporal-Connection-Type-Value E29 before
T66	Study 283 291	baseline
E30	Study:T66 
T67	Observation 343 347	MMSE
E31	Observation:T67 Name:T68 Eq-Comparison:E24
T68	Observation-Name 343 347	MMSE
R2	Equivalent-To Arg1:E31 Arg2:E13	
T69	Observation 360 363	CDR
E32	Observation:T69 Name:T70 Eq-Comparison:E33
T70	Observation-Name 360 363	CDR
T71	Eq-Comparison 364 369	>/= 1
E33	Eq-Comparison:T71 Operator:T25 Value:T37
T72	Or 353 359	and/or
E34	Or:T72 Arg:E31 Arg2:E32
T73	Condition 412 414	AD
E35	Condition:T73 Name:T74
T74	Condition-Name 412 414	AD
T75	Exception 407 411	than
E36	Exception:T75 From:E15 Except:E35
T76	Severity 445 456	Significant
A20	Severity-Value T76 severe
T77	Stability 473 481	Unstable
A21	Stability-Value T77 change
T78	Or 505 507	or
E37	Or:T78 Arg:E5 Arg2:E9
T79	Procedure 533 542	treatment
E38	Procedure:T79 
R3	Treatment-For Arg1:E38 Arg2:E9	
T80	Assertion 525 532	need of
E39	Assertion:T80 Asserted:E38
A22	Assertion-Type-Value E39 hypothetical
T81	Condition 557 578	inflammatory diseases
E40	Condition:T81 Name:T82
T82	Condition-Name 557 578	inflammatory diseases
T83	Other 377 382	Other
E41	Other:T83 Is-Other:E15
T84	Other 420 425	Other
E42	Other:T84 Is-Other:E7
T85	Condition 584 599	Somatic disease
E43	Condition:T85 Name:T86
T86	Condition-Name 584 599	Somatic disease
T87	Condition 618 636	cognitive function
E44	Condition:T87 Name:T88
T88	Condition-Name 618 636	cognitive function
T89	Stability 611 617	affect
A23	Stability-Value T89 change
R4	Equivalent-To Arg1:E44 Arg2:T89	
T90	Assertion 605 610	might
E45	Assertion:T90 Asserted:T89
A24	Assertion-Type-Value E45 hypothetical
R5	Caused-By Arg1:T89 Arg2:E43	
T91	Drug 661 675	anticoagulants
E46	Drug:T91 Name:T92 Temporality:E47
T92	Drug-Name 661 675	anticoagulants
T93	Eq-Comparison 652 657	Usage
E47	Eq-Comparison:T93 Temporal-Period:T94
T94	Eq-Temporal-Period 652 657	Usage
A25	Eq-Temporal-Period-Value T94 present
T95	Eq-Comparison 681 686	Prior
E48	Eq-Comparison:T95 Temporal-Period:T96
T96	Eq-Temporal-Period 681 686	Prior
A26	Eq-Temporal-Period-Value T96 past
T97	Or 698 700	or
E49	Or:T97 Arg:E19 Arg2:E17
T98	Condition 734 737	CNS
E50	Condition:T98 Name:T99
T99	Condition-Name 734 737	CNS
T100	Stability 724 733	affecting
A27	Stability-Value T100 change
R6	Equivalent-To Arg1:E50 Arg2:T100	
T101	Assertion 715 723	possibly
E51	Assertion:T101 Asserted:T100
A28	Assertion-Type-Value E51 hypothetical
R7	Caused-By Arg1:T100 Arg2:E17	
T102	Condition 752 758	cancer
E52	Condition:T102 Name:T103
T103	Condition-Name 752 758	cancer
T104	Condition 776 783	disease
E53	Condition:T104 Name:T105 Severity:T106
T105	Condition-Name 776 783	disease
T106	Severity 768 775	serious
A29	Severity-Value T106 severe
T107	Other 762 767	other
E54	Other:T107 Is-Other:E53
T108	Observation 789 806	expected survival
E55	Observation:T108 Name:T109 Eq-Comparison:E25
T109	Observation-Name 789 806	expected survival
T110	And 784 788	with
E56	And:T110 Arg:E53 Arg2:E55
T111	Drug 822 831	Fish meal
E57	Drug:T111 Name:T112 Eq-Comparison:E58
T112	Drug-Name 822 831	Fish meal
T113	Eq-Comparison 839 863	more than 2 times a week
E58	Eq-Comparison:T113 Operator:T114 Value:T39 Per:T115
T114	Eq-Operator 839 848	more than
A30	Eq-Operator-Value T114 GT
T115	Eq-Temporal-Unit 859 863	week
A31	Eq-Temporal-Unit-Value T115 week
T40	Drug 889 908	Omega-3 supplements
E59	Drug:T40 Name:T116 Temporality:E60 Temporality2:E61
T116	Drug-Name 889 908	Omega-3 supplements
T117	Eq-Comparison 869 878	Regularly
E60	Eq-Comparison:T117 Temporal-Period:T118
T118	Eq-Temporal-Period 869 878	Regularly
A32	Eq-Temporal-Period-Value T118 present
T119	Eq-Comparison 918 931	last 3 months
E61	Eq-Comparison:T119 Temporal-Period:T120 Value:T41 Temporal-Unit:T30
T120	Eq-Temporal-Period 918 922	last
A33	Eq-Temporal-Period-Value T120 past
T121	Modifier 548 556	Systemic
E62	Modifier:T121 Modifies:T82
